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The present investigation of several barrier creams in use as protectives in
industry and in the household, was undertaken to study their possible primary
irritant or eczematogenous activity. No mention of this aspect of the barrier
creams was found in the available literature (cf. the excellent thesis of Herrmann
(1) who gives more than 130 references).
The barrier creams under investigation were applied to the skin by a standard
patch test technic: a piece of cotton cloth of about cm2 was covered by plastic
material and adhesive plaster, and left on the skin for 48 hours.
The results in 300 patients, suffering from various dermatoses, are shown in
Table I.
The most striking result of the tests is the high percentage of positive reactions
caused by the oil resistant creams, Kerodex B.D. with 50 per cent and Magnor
red with 25 per cent. The water resistant creams, Magnor white and Kerodex
B.W., show a much lower percentage of positive reactions and least of all the
silicone creams.
Most of the reactions were of the primary irritant type, characterized by
circumscribed erythema or by a blister but five were of the eczematous type.
Specimens of both types were examined histologically and the clinical impression
as to the type of reaction was confirmed. The eczematous type reactions may be
explained as being due to an isomorphic reaction. It might be argued that the
high percentage of positive tests of the primary irritant type is partly due to
higher sensitivity of eczematous skin, 90 per cent of the tested subjects being
eczematous patients. However, this does not detract from the fact that the inves-
tigated creams possess a certain irritative quality. Of the 33 patients with derma-
toses other than eczema, 15 were positive with Kerodex B.D. and 18 negative,
approximately the same percentage as in the eczema cases. Moreover, proper
controls were made, and every patient was tested with thirteen different sub-
stances, t which showed a negative reaction, except in cases of true allergic sensi-
tivity to certain contactants.
DISCUSSION
A remarkably high incidence of up to 50 per cent positive patch tests was
found with several barrier creams. Even the least reacting creams, with a silicone
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t The tested substances were: aqueous solutions of potassium bichromate )/2%, nickel
sulfate 5%, procaine hydrochloride 2%, formaline 5%, chinine hydrochlorate 1%, resorcinol
1%, corrosive sublimate 1%, sodium arsenicate 1%, naphthaline per Se, paraphenylene di-
amine and sulfanilamide in vaseline, 2% and 10% respectively, and kerosene and turpentine
in olive oil 60% and 50% respectively.
223
224 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
TABLE I
Results of 300 patch tests with vaious barrier creams
Number of
Positive Tests ercentage
Kerodex' B.W
Kerodex' B.D
Magnor' white
Magnor4 red
Covicone5
Silicote6
11 3.7
149 49.7
44 14.7
75 25
6 2
2 0.7
Kerodex, Scientific Pharmacals, London.
'Kerodex B.W. (BW1, BW2, BW3, BW4) is a water resistant cream: boro stearates,
fatty alcohols, metal stearates, zinc oxide, diatamaceous earths, siliceous earths, gums,
emulsifiers.
2 Kerodex B.D. (BD5, BD6, BD7, BD8) is an oil resistant cream: aerates, stearates, boro
stearates, fatty alcohols, cholesterols, wool alcohols, lanolin derivates, metal stearates,
diatamaceous earths, kaolin, gums, alginates, emulsifiers, preservatives, colour, glycerin,
water.
Magnor (Taya, Tel Aviv).
Magnor white is a water resistant cream: latex, cold cream, higher poliols, preserva-
tives.
Magnor red is an oil resistant cream: methyl cellulose, sulphonated fatty alcohols,
soap, glycerin, higher poliols, preservatives.
Covicone Cream (Abbott) is a plasticized combination of silicone, nitrocellulose and
castor oil.
6 Silicote Cream (Arnar Stone) is 30 per cent silicone in U.S.P. petrolatum album.
base, showed a number of positive reactions which was not negligible, and which
would have disqualified these creams if "prophetic" patch tests would have been
performed prior to their introduction in industry.
These creams, however, have been used with great success in the prevention of
industrial dermatoses. The difference between the circumstances in actual usage
and in the patch tests is clear. There is considerable difference between a cream
applied for 48 hours under an occlusive bandage and one applied for only a few
hours without a covering. The factor of sweating under the patch test is appar-
ently not very important, because this study was extended over two hot summers
and two cold winters, and no difference in the frequency of positive tests was
found in connection with the season.
The well known clinical fact that barrier creams easily provoke an exacerbation
in an inflamed skin, can be explained by the slightly irritant action of the creams.
Therefore they should only be used on a healthy skin for prophylactic purposes.
It could not be ascertained in this study which of the chemicals caused the
skin reactions.
Addendum: After this study was finished, the paper of Kuske, Klayman and
Schwarz (3) and the thesis of Klayman (2) came to our attention. These authors
found an even higher percentage of reactions of the primary irritant type with
barrier creams. Thirty patients were tested with Kerodex. With the oil resistant
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Kerodex B.D. 21 reactions of the primary irritant type were found in 30 patients,
whereas with the water resistant Kerodex B.W. only 4 patients showed these
reactions.
SUMMARY
1. Forty-eight hour patch tests were performed with several barrier creams on
300 patients mostly suffering from eczema.
2. There was a wide range (from less than 1 per cent up to 50 per cent) in the
incidence of positive reactions to the different creams used in the investigation.
The reactions were almost exclusively of the primary irritant type.
3. The high incidence of positive reactions to some creams does not detract
from their considerable prophylactic usefulness. The actual usage is not compa-
rable with the patch test.
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